These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1461650)

  • 1. c-myc and p53 gene expression in the differentiation of temperature-sensitive mutants of teratocarcinoma F9 cells.
    Kosaka M; Iwai SA; Nishina Y; Sumi T; Nishimune Y
    Oncogene; 1992 Dec; 7(12):2455-60. PubMed ID: 1461650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of early growth-associated events during the differentiation of F9 cells into embryoid bodies.
    Whitman MM; Shen YM; Soprano D; Soprano KJ
    Cancer Res; 1990 Jun; 50(11):3193-8. PubMed ID: 2139801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wild-type p53-triggered apoptosis is inhibited by bcl-2 in a v-myc-induced T-cell lymphoma line.
    Wang Y; Szekely L; Okan I; Klein G; Wiman KG
    Oncogene; 1993 Dec; 8(12):3427-31. PubMed ID: 8247547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of F9 cells is independent of c-myc expression.
    Nishikura K; Kim U; Murray JM
    Oncogene; 1990 Jul; 5(7):981-8. PubMed ID: 1695728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
    Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
    Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered steady-state levels of the messenger RNAs for c-myc and p53 in L1210 cell lines resistant to deoxyadenosine.
    Cory JG; Cory AH; Long SD; Carter GL; Johnson CE
    Cancer Res; 1992 Apr; 52(7):2000-3. PubMed ID: 1551129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transcription of c-fos gene and DNA binding activity of transcription factor AP-1 increase upon differentiation of mouse F9 teratocarcinoma cells].
    Chuĭkin IA; Lianguzova MS; Pospelov VA
    Tsitologiia; 2004; 46(12):1080-90. PubMed ID: 15747838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-myc expression affects proliferation but not terminal differentiation or survival of explanted erythroid progenitor cells.
    Bondurant MC; Yamashita T; Muta K; Krantz SB; Koury MJ
    J Cell Physiol; 1996 Aug; 168(2):255-63. PubMed ID: 8707861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
    Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
    Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of EGR-1, c-jun, and c-myc gene expression by oncostatin M.
    Liu J; Clegg CH; Shoyab M
    Cell Growth Differ; 1992 May; 3(5):307-13. PubMed ID: 1633113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in expression of members of the fos and jun families and myc network during terminal differentiation of human keratinocytes.
    Gandarillas A; Watt FM
    Oncogene; 1995 Oct; 11(7):1403-7. PubMed ID: 7478564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet irradiation, although it activates the transcription factor AP-1 in F9 teratocarcinoma stem cells, does not induce the full complement of differentiation-associated genes.
    Auer HP; König H; Litfin M; Stein B; Rahmsdorf HJ
    Exp Cell Res; 1994 Sep; 214(1):131-8. PubMed ID: 7521841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous c-myc gene overexpression interferes with early events in F9 cell differentiation.
    Onclercq R; Babinet C; Cremisi C
    Oncogene Res; 1989; 4(4):293-302. PubMed ID: 2671866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Hox1.6, c-jun, and Oct-3 gene expressions are associated with teratocarcinoma F9 cell differentiation in three different ways of induction.
    Iwai SA; Kosaka M; Nishina Y; Sumi T; Sakuda M; Nishimune Y
    Exp Cell Res; 1993 Mar; 205(1):39-43. PubMed ID: 8453995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinate change of c-myc, transferrin receptor and H3 gene expression precedes induction of haemoglobin-producing cells of the leukaemia K562 cell line treated with cis-diamminedichloroplatinum (II).
    Marazzi L; Parodi MT; Di Martino D; Ferrari S; Tonini GP
    Anticancer Res; 1991; 11(2):947-52. PubMed ID: 2064352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The proliferation-associated early response gene p22/PRG1 is a novel p53 target gene.
    Schäfer H; Trauzold A; Sebens T; Deppert W; Fölsch UR; Schmidt WE
    Oncogene; 1998 May; 16(19):2479-87. PubMed ID: 9627114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of jun genes during the reversible changes induced with sodium butyrate on the differentiation of F9 cells.
    Nishina Y; Sumi T; Iwai SA; Kosaka M; Nishimune Y
    Exp Cell Res; 1993 Oct; 208(2):492-7. PubMed ID: 8375477
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential regulation of N-myc and c-myc expression in F9 teratocarcinoma cells.
    Finklestein R; Weinberg RA
    Oncogene Res; 1988; 3(3):287-92. PubMed ID: 3060804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TPA-induced differentiation of human rhabdomyosarcoma cells involves dephosphorylation and nuclear accumulation of mutant P53.
    Germani A; Fusco C; Martinotti S; Musarò A; Molinaro M; Zani BM
    Biochem Biophys Res Commun; 1994 Jul; 202(1):17-24. PubMed ID: 8037710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of the c-myb, c-myc and p53 mRNA and protein levels during induced murine erythroleukemia cell differentiation.
    Richon VM; Ramsay RG; Rifkind RA; Marks PA
    Oncogene; 1989 Feb; 4(2):165-73. PubMed ID: 2648254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.